Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > posted this on nov. 4, now we know what was fishy

<< Previous

Bullboard Posts

Next >>

Comment by pelabooston Nov 09, 2023 11:17am

163 Views

Post# 35726159

RE:RE:posted this on nov. 4, now we know what was fishy

@itntdf. You were correct.
First, I should say I think PanCAN is a fine organization.

However, I did ask several weeks ago if we really needed PanCAN. From my lay perspective I was trying to imagine the thinking of an entity that might be spending a billion of more. I thought PanCAN with all their strengths just might be in the way.

I am now going to spend a considerable amount of time updating my lay understanding of the situation.

I do imagine myself to be adding.

Cheers

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide